FDA Approves Synjardy XR (empagliflozin/metformin hydrochloride extended-release) for Adults with Type 2 Diabetes

RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 12, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Synjardy XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When used...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news

Related Links:

DIABETES type 2 sufferers could lower their blood sugar through diet changes. Symptoms someone is suffering from high blood sugar include increased thirst, headaches and blurred vision. Eating this food could help lower blood sugar levels.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
DIABETES type 2 sufferers could lower their blood sugar through diet changes. Symptoms someone is suffering from high blood sugar include increased thirst, headaches and blurred vision. Eating this food could help lower blood sugar levels.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
ConclusionsBoth obese and non-obese people with T2DM had higher BMD, at lumbar spine and femoral neck, compared with healthy subjects. In addition, the prevalence of osteoporosis significantly decreased with blood glucose and HbA1c.
Source: Archives of Orthopaedic and Trauma Surgery - Category: Orthopaedics Source Type: research
This study was done, due to a continuous increase in the risk of obesity and type 2 diabetes in north Indian population, because of lifestyle and genetic variations. Clinically diagnosed subjects of type 2 diabetes mellitus (as per ADA criteria) were taken as cases and age and sex matched subjects without any associated illness were taken as controls. Obesity was estimated by calculating waist circumference and BMI in the study cases and controls. For genetic variation, DNA was isolated with Quaigen kit method and isolated DNA was amplified with PCR. Amplified DNA was resolved in 1% agarose gel electrophoresis. The Hardy &...
Source: Indian Journal of Clinical Biochemistry - Category: Biochemistry Source Type: research
Conclusion: No safety issues were revealed with either basal insulin. Due to the low number of patients recruited, no efficacy conclusions could be drawn.ClinicalTrials.govidentifier: NCT02131272.What is known:• There is a growing worldwide epidemic of type 2 diabetes in children and adolescents.• There is a lack of research and limited treatment options currently available in this population.What is new:• No safety issues with insulin detemir or neutral protamine Hagedorn insulin in children and adolescents with type 2 diabetes were observed.• Improving clinical trial recruitment, along with providing ...
Source: European Journal of Pediatrics - Category: Pediatrics Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
DIABETES type 2 symptoms can include unexplained weight loss and feeling very tired. Passing more urine than normal could also be a warning sign of high blood sugar. But, what counts as a normal amount of toilet trips?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
Conclusion: The significant correlations between PAI-1 levels and lipoprotein subfractions indicate the link between PAI-1 and lipid metabolism in obesity. PMID: 30002679 [PubMed]
Source: International Journal of Endocrinology - Category: Endocrinology Tags: Int J Endocrinol Source Type: research
The global incidence of hepatocellular carcinoma (HCC) has increased to more than 700,000 cases annually. HCC has emerged as the third leading cause of cancer-related mortality worldwide[1]. Type 2 diabetes mellitus (T2DM) is also a global health problem. In 2013, the International Diabetes Federation estimated that there were 380 million diabetics worldwide[2]. Seeing that the incidence of both HCC and T2DM are increasing rapidly, a subset of people must be affected with HCC and T2DM. Clinical data has shown an association between the presence of diabetes and higher incidence and poorer prognosis of HCC, which suggest tha...
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research
The prevalence of type 2 diabetes mellitus (T2DM), which results in many micro- and macrovascular complications with major morbidity, mortality, reduced quality of life and increased society costs, is rapidly increasing worldwide and is becoming a major global health issue [1 –3]. Diabetic foot ulcer (DFU), which is often associated with infection, peripheral neuropathy and peripheral arterial disease, is one of the most serious and problematic complications of diabetes and has been considered the most important predictor for lower-extremity amputations [4].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Source Type: research
More News: Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Empagliflozin | Endocrinology | Food and Drug Administration (FDA) | Fortamet | Jardiance | Metformin